Espumisan caps. 40mg # 25

Release form, composition and packaging

Capsules are gelatinous, round, with a seam and a smooth surface, yellow

contents of capsules - colorless, viscous, slightly opalescent liquid

1 caps.

simethicone 40 mg

gelatin - 22.47 mg, glycerol 85% - 9.67 mg, methyl parahydroxybenzoate - 0.28 mg, quinoline yellow dye (E104) - 0.1 mg, sunset yellow dye (E110) - 0.0024 mg

25 pcs.

- blisters (1) - cardboard packs.

25 pcs.

- blisters (2) - cardboard packs.

25 pcs.

- blisters (4) - cardboard packs.

pharmachologic effect

Carminative.

The active substance, simethicone, has surface activity and the ability to reduce surface tension at the liquid / gas interface.

In this case, gas bubbles merge and the foam breaks down, as a result of which the released gas is able to be absorbed or excreted naturally under the influence of intestinal peristalsis.

The use of the drug Espumisan for preparation for diagnostic studies prevents the occurrence of image defects caused by gas bubbles.

Pharmacokinetics

Simethicone is chemically inert, after oral administration it is not absorbed from the gastrointestinal tract and acts only in its lumen.

Does not affect enzymes and microorganisms present in the digestive tract.

It is displayed unchanged.

Indications for use

excessive formation and accumulation of gases in the gastrointestinal tract (flatulence, Remheld's syndrome, aerophagia, increased gas production in the postoperative period)

preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (including ultrasound, X-ray examinations)

symptoms of excessive gas formation caused by functional dyspepsia

acute poisoning with detergents containing foaming agents (as an antifoam agent).

Contraindications for use

intestinal obstruction

children under 6 years old

hypersensitivity to drug components.

Dosage regimen

For complaints related to excessive gas formation, adults and children over 6 years of age are prescribed 2 caps.

3-5 times / day, it is possible with a small amount of liquid, after each meal and, if necessary, before bedtime.

The duration of the course of treatment depends on the presence of symptoms of increased gas production.

If necessary, Espumisan can be used for a long period of time.

In preparation for diagnostic tests, 2 capsules are prescribed.

3 times / day the day before the study and in the morning of the study day 2 caps., Without drinking water

As a defoamer in case of poisoning with detergents containing foaming substances, a single dose for adults is 10-20 caps., For children over 6 years old - 3-10 caps.

in one go

the dose depends on the severity of the intoxication.

Overdose

An overdose of the drug Espumisan is unlikely due to the chemical and physiological inertness of the drug.

Side effect

There were no side effects when taking Espumisan

Development of allergic reactions to auxiliary components of the drug is possible.

Drug interactions

Clinically significant interaction of the drug Espumisan with other drugs has not been established.

Application during pregnancy and lactation

The drug Espumisan can be used during pregnancy and during breastfeeding.

Special instructions In people with hypersensitivity to the components of the drug (methyl parahydroxybenzoate and quinoline yellow dye), immediate hypersensitivity reactions, as well as delayed-type hypersensitivity reactions, may occur.

If any allergic reactions occur, the drug should be stopped immediately and a doctor should be consulted.

Influence on the ability to drive vehicles and control mechanismsThe drug Espumisan does not affect the speed of psychomotor reactions and the ability to perceive or

Name ENG

ESPUMISAN

Clinical and pharmacological group

A drug that reduces flatulence

ATX code

Silicones

Dosage

40mg

Structure

Active ingredients: simethicone 40 mg.

Excipients: gelatin - 22.47 mg, glycerol 85% - 9.67 mg, methyl parahydroxybenzoate - 0.28 mg, quinoline yellow dye (E104) - 0.1 mg, sunset yellow dye (E110) - 0.0024 mg ...

Indications

Excessive formation and accumulation of gases in the gastrointestinal tract (flatulence, Remheld's syndrome, aerophagia, increased gas production in the postoperative period)

preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (including ultrasound, X-ray examinations)

symptoms of excessive gas formation caused by functional dyspepsia

acute poisoning with detergents containing foaming agents (as an antifoam agent).

INN / Active ingredient

simethicone

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 5 years

Contraindications

Hypersensitivity to drug components

intestinal obstruction.

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the drug

Gastrointestinal tract

Release form

Capsules

Manufacturer country

Germany

Package quantity, pcs

25

Scope of application

Gastroenterology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Berlin-Chemie

The amount of the dosage form in the primary package

25 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Carminative

Anatomical and therapeutic characteristics

A03AX13 Silicones

Dosage form

Capsules

Dosage (volume) of the substance in the preparation

40 mg

Expiration date in days

1825

Package weight, g

ten

Mode of application

:

Information on technical characteristics, delivery set, country of manufacture